SINGAPORE, Jan 10 (Bloomberg): Singapore saw the fewest deaths among those with the Moderna Inc shot and the most among those with Sinovac Biotech Ltd.’s vaccine, as the city-state’s highly inoculated population provides a glimpse into how different immunisations are holding up in the real world.
The data is likely to add to further concerns about the effectiveness of the widely-used Chinese vaccine, which studies have found to be inadequate against the omicron variant.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!